Posts Tagged ‘Biotech’
ObsEva plans job cuts
The ObsEva laboratory is to engage in a vast restructuring process in the face of difficulties encountered with the FDA with its drug in development Linzagolix. Job cuts might be on the agenda. The US Drug Administration (FDA) agreed in November 2021 to review the application for the drug to treat heavy periods associated with…
Read MoreNestlé Health Science invests EUR 40 million in Enterome
Nestlé Health Science has signed a collaboration agreement with French company Enterome to target food allergies and chronic intestinal diseases Enterome develops new treatments for cancer and autoimmune diseases based on its unique knowledge of the microbiota. With Nestlé Health Science, the french company intends to work on the development of an experimental treatment,…
Read MoreNestlé Health Science and Perseo Pharma partners to fight digestive diseases
Strategic collaboration to create therapies against digestive diseases Perseo pharma, a preclinical stage biopharmaceutical company focused on breaking new ground in enzyme therapies, has entered a strategic research and development collaboration with Nestlé Health Science S.A. to develop up to three programs targeting enzyme deficiencies in patients suffering from digestive diseases. “We are incredibly…
Read MoreKBI Biopharma SA and Selexis SA inaugurated a new facility in Geneva
KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development and manufacturing services facility in Plan-les-Ouates in Geneva, Switzerland. The ~8 700 m2 integrated KBI/Selexis state-of-the-art facility builds upon the companies’ existing market foothold by combining best-in-class cell line development (CLD) and expert mammalian cell…
Read MoreVaud invests CHF 178 Million in Life Sciences
To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne in Life Sciences, the State Council is requesting five investment credits totaling CHF 178.71 million from the Grand Council. In Dorigny, these investments would allow the construction of a life sciences building and, in…
Read MoreGeneva researcher wins European Inventor’s Award
Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded for her therapeutic vaccines against cancer. The European Patent Office (EPO) awarded the two researchers the European Inventor Award 2022 in the “SME” category at a ceremony in Munich on Tuesday. The teammates have…
Read Moreten23health is building a new facility in Visp
The company plans to establish a new 5,000 m2 manufacturing facility in Visp. In October 2021, ten23 health acquired a former Swissfillon site to install its production facility. In March 2022, a first 1,000 m2 expansion was announced. The new 5,000 m2 facility will include sterile manufacturing lines plus laboratories, offices and technical areas across…
Read MoreLimula wins a prestigious EIC grant of €4.7 million
By combining its novel bioreactor with state-of-the-art sensors and predictive data intelligence, Limula will add significant value to its cell & gene therapy manufacturing solution, paving the way for in-process control for the production of highly personalised cancer treatments.
Read MoreBioAlps at OM Pharma
On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma in Geneva. OM Pharma is a leader in the prevention of recurrent respiratory and urinary tract infections with products regulating the immune system based on oral bacterial extracts. Broncho-Vaxom® and Uro Vaxom® are marketed…
Read MoreCytiva opens a new production site in Grens (VD)
Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022. The site will manufacture single-use kits for the Sepax and Sefia cell processing systems, as well as consumables for the Xuri cell expansion systems. The new site will be home to 250 employees and house the Centre of Excellence…
Read More